EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Colorectal Cancer Puzzle: m6A Modification and Its Intricate Relationship With Drug Resistance

Mengxiang Yang, Zhihui Dai, Yuejun Han, Yijing Shen, Jianping Wang

Frontiers in Bioscience-Landmark · 2026

DOI: 10.31083/fbl45750 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Mengxiang Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, 321000 Jinhua, Zhejiang, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Colorectal Neoplasms, Adenosine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jinhua Municipal Science and Technology Projects, Special Research Fund for Basic Research of Jinhua Central Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a globally prevalent malignancy with rising incidence and mortality rates over the past decades. N6-methyladenosine (m6A) is the most abundant internal RNA modification in eukaryotes, and plays a pivotal role in post-transcriptional regulation. m6A is dynamically modulated by three core components, namely methyltransferases (writers), demethylases (erasers), and binding proteins (readers), which together govern the transcription, processing, translation, decay, and stability of mRNA. There has been accumulating evidence for the association of dysregulated m6A modification with CRC pathogenesis, metastasis, and therapeutic resistance. This review summarizes the biogenesis of m6A modification and its regulatory mechanisms, and discusses the dysregulation of m6A-related factors in CRC and the functional impacts. Most importantly, the review highlights the key roles of m6A modification in mediating CRC resistance to chemotherapy, targeted therapy, and immunotherapy. These insights may facilitate the development of novel therapeutic strategies for CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmColorectal NeoplasmsAdenosineHumansRNA MethylationGene Expression Regulation, NeoplasticEpitranscriptomeAnimals

Stichwörter der Autor:innen

N6-methyladenosineRNA demethylasesRNA methyltransferasescolorectal neoplasmsdrug resistance

Substanzen

AdenosineN-methyladenosine

Autor:innen und Institutionen

  • Department of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, 321000 Jinhua, Zhejiang, China.
  • Department of General Surgery, The Second Affiliated Hospital of Soochow University, 215100 Suzhou, Jiangsu, China.
  • Department of Scientific Research, The Affiliated Women and Children's Hospital of Ningbo University, 315100 Ningbo, Zhejiang, China.

Förderung

  • Jinhua Municipal Science and Technology Projects
  • Special Research Fund for Basic Research of Jinhua Central Hospital

Zitieren

APA

Yang, M., Dai, Z., Han, Y., Shen, Y., & Wang, J. (2026). Colorectal Cancer Puzzle: m6A Modification and Its Intricate Relationship With Drug Resistance. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl45750

Vancouver

Yang M, Dai Z, Han Y, Shen Y, Wang J. Colorectal Cancer Puzzle: m6A Modification and Its Intricate Relationship With Drug Resistance. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl45750

BibTeX
@article{Yang2026,
  author = {Yang, Mengxiang and Dai, Zhihui and Han, Yuejun and Shen, Yijing and Wang, Jianping},
  title = {Colorectal Cancer Puzzle: m6A Modification and Its Intricate Relationship With Drug Resistance},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  doi = {10.31083/fbl45750}
}
Kostenlos starten →